Komori
Daito Pharmaceutical (4577) · RiskMitigated

Risk of Environmental Impacts from Chemical Substances

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2022.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018WorsenedFY20192016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 12022
Same theme, other companies
Risk of Using Hazardous Chemicals, Biological Materials and Hazardous WasteA theme 20 companies write about · 19 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2021: 1 of 7 companies on the "Worse" side.

1 other company's latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 20 companies compared. The sentences above are computed from all 20.
Full recordFilings, disclosures and news, newest first
  1. FY2022MitigatedAnnual report

    「To address these risks, the Group complies with laws and regulations related to environmental protection, establishes strict procedures for the storage and handling of chemical substances, and implements appropriate management through monitoring to prevent soil pollution, water pollution and unpleasant odors.」

    The company explicitly describes stricter storage and handling procedures and appropriate management through monitoring as measures addressing the risks of environmental impact from chemical substances and revisions to environmental regulations.
  2. FY2019WorsenedAnnual report

    「The Group’s operating results and other aspects of its performance may also be affected if substantial costs for countermeasures arise following revisions to laws and regulations related to environmental protection.」

    The company explicitly identifies the risk of pollution and unpleasant odors from chemical substances, as well as the potential for substantial countermeasure costs following revisions to environmental regulations.
  3. FY2018RestatedAnnual report

    「Some of the chemical substances used in the research and manufacturing processes for pharmaceuticals may adversely affect human health and ecosystems.」

    The risks of environmental impact from chemical substances, environmental regulations, soil and water pollution, and unpleasant odors continue to be disclosed.
  4. FY2017RestatedAnnual report

    「Some of the chemical substances used in the research and manufacturing processes for pharmaceuticals may adversely affect human health and ecosystems.」

    The risks of environmental impact from chemical substances, environmental regulations, soil and water pollution, and unpleasant odors continue to be disclosed.
  5. FY2016First statedAnnual report

    「Some of the chemical substances used in the research and manufacturing processes for pharmaceuticals may adversely affect human health and ecosystems.」

    The company states that it is working to comply with applicable laws and regulations and prevent soil and water pollution and the occurrence of unpleasant odors.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Environmental Impacts from Chemical Substances | Daito Pharmaceutical Co.,Ltd. (4577) | Komori